Clinical advances in investigational epilepsy treatments
Although the first clinical breakthroughs have been achieved in the causal therapy of epilepsy using cell therapy and antisense oligonucleotides, larger clinical and observational studies are needed after the wider application of these therapeutic methods to evaluate their true place in epilepsy therapy. Symptomatic antiseizure medication has achieved significantly greater success in clinical practice by acting through several different mechanisms, and in the future, the reduction of the number of patients who will not respond favorably to any form of antiseizure medication could be expected.
Authors
- Slobodan Јаnkovic (ORCID: https://orcid.org/0000-0002-1519-8828)
Institutions
- University of Kragujevac (RS)
Publication Details
- Journal
- Expert Opinion on Investigational Drugs
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1080/13543784.2025.2574992
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00